162 related articles for article (PubMed ID: 8913341)
1. Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.
Iredale PA; Terwilliger R; Widnell KL; Nestler EJ; Duman RS
Mol Pharmacol; 1996 Nov; 50(5):1103-10. PubMed ID: 8913341
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
[TBL] [Abstract][Full Text] [Related]
5. Regulation of pituitary corticotropin releasing factor type-1 receptor mRNA binding proteins by modulation of the hypothalamic-pituitary-adrenal axis.
Wu Z; Ji H; Hassan A; Aguilera G; Sandberg K
J Neuroendocrinol; 2004 Mar; 16(3):214-20. PubMed ID: 15049852
[TBL] [Abstract][Full Text] [Related]
6. Corticotrophin-releasing factor type 2 receptor-mediated suppression of gonadotrophin-releasing hormone mRNA expression in GT1-7 cells.
Kinsey-Jones JS; Li XF; Bowe JE; Lightman SL; O'Byrne KT
Stress; 2006 Dec; 9(4):215-22. PubMed ID: 17175507
[TBL] [Abstract][Full Text] [Related]
7. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
Huang Q; Timofeeva E; Richard D
J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401
[TBL] [Abstract][Full Text] [Related]
8. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
Korosi A; Veening JG; Kozicz T; Henckens M; Dederen J; Groenink L; van der Gugten J; Olivier B; Roubos EW
Brain Res; 2006 Feb; 1072(1):46-54. PubMed ID: 16423327
[TBL] [Abstract][Full Text] [Related]
9. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
[TBL] [Abstract][Full Text] [Related]
10. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures.
Pozzoli G; Bilezikjian LM; Perrin MH; Blount AL; Vale WW
Endocrinology; 1996 Jan; 137(1):65-71. PubMed ID: 8536643
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of corticotropin-releasing factor (CRF) and urotensin I precursor genes, and evidence of CRF gene expression regulated by cortisol in goldfish brain.
Bernier NJ; Lin X; Peter RE
Gen Comp Endocrinol; 1999 Dec; 116(3):461-77. PubMed ID: 10603283
[TBL] [Abstract][Full Text] [Related]
13. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
[TBL] [Abstract][Full Text] [Related]
14. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of the inferior olivary complex alters the distribution of the type 1 corticotropin releasing factor receptor in the adult rat cerebellar cortex.
Tian JB; King JS; Bishop GA
Neuroscience; 2008 Apr; 153(1):308-17. PubMed ID: 18358620
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain.
Kostich WA; Grzanna R; Lu NZ; Largent BL
J Comp Neurol; 2004 Oct; 478(2):111-25. PubMed ID: 15349973
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats.
Kim SJ; Park SH; Choi SH; Moon BH; Lee KJ; Kang SW; Lee MS; Choi SH; Chun BG; Shin KH
Neuropharmacology; 2006 Jun; 50(7):824-33. PubMed ID: 16504218
[TBL] [Abstract][Full Text] [Related]
18. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems.
Gilmor ML; Skelton KH; Nemeroff CB; Owens MJ
J Pharmacol Exp Ther; 2003 May; 305(2):434-9. PubMed ID: 12606697
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional response to corticotropin-releasing factor in AtT-20 cells.
Peeters PJ; Göhlmann HW; Van den Wyngaert I; Swagemakers SM; Bijnens L; Kass SU; Steckler T
Mol Pharmacol; 2004 Nov; 66(5):1083-92. PubMed ID: 15272051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
